Return On Assets in % of Mersana Therapeutics, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Mersana Therapeutics, Inc. quarterly/annual Return On Assets history and change rate from Q1 2018 to Q3 2025.
  • Mersana Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -69.3 %, a 79.5% decline year-over-year.
  • Mersana Therapeutics, Inc. annual Return On Assets for 2024 was -40 %, a 36.1% increase from 2023.
  • Mersana Therapeutics, Inc. annual Return On Assets for 2023 was -62.6 %, a 11.1% increase from 2022.
  • Mersana Therapeutics, Inc. annual Return On Assets for 2022 was -70.4 %, a 4.2% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Mersana Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -69.3 -30.7 -79.5% 01 Jul 2025 30 Sep 2025
Q2 2025 -57.9 -9.56 -19.8% 01 Apr 2025 30 Jun 2025
Q1 2025 -48.9 +5.15 +9.53% 01 Jan 2025 31 Mar 2025
Q4 2024 -40 +22.6 +36.1% 01 Oct 2024 31 Dec 2024
Q3 2024 -38.6 +26.8 +41% 01 Jul 2024 30 Sep 2024
Q2 2024 -48.4 +20.2 +29.4% 01 Apr 2024 30 Jun 2024
Q1 2024 -54 +17.2 +24.1% 01 Jan 2024 31 Mar 2024
Q4 2023 -62.6 +7.79 +11.1% 01 Oct 2023 31 Dec 2023
Q3 2023 -65.4 +15.3 +19% 01 Jul 2023 30 Sep 2023
Q2 2023 -68.5 +14.5 +17.5% 01 Apr 2023 30 Jun 2023
Q1 2023 -71.2 +6.9 +8.84% 01 Jan 2023 31 Mar 2023
Q4 2022 -70.4 +3.09 +4.2% 01 Oct 2022 31 Dec 2022
Q3 2022 -80.8 -20.3 -33.7% 01 Jul 2022 30 Sep 2022
Q2 2022 -83 -35.4 -74.2% 01 Apr 2022 30 Jun 2022
Q1 2022 -78.1 -40.4 -107% 01 Jan 2022 31 Mar 2022
Q4 2021 -73.5 -37.2 -102% 01 Oct 2021 31 Dec 2021
Q3 2021 -60.4 -22.9 -61% 01 Jul 2021 30 Sep 2021
Q2 2021 -47.7 -3.77 -8.59% 01 Apr 2021 30 Jun 2021
Q1 2021 -37.7 +20 +34.7% 01 Jan 2021 31 Mar 2021
Q4 2020 -36.3 -14.5 -66.7% 01 Oct 2020 31 Dec 2020
Q3 2020 -37.5 -9.4 -33.4% 01 Jul 2020 30 Sep 2020
Q2 2020 -43.9 -13.9 -46.1% 01 Apr 2020 30 Jun 2020
Q1 2020 -57.7 -29.8 -107% 01 Jan 2020 31 Mar 2020
Q4 2019 -21.8 +43.2 +66.5% 01 Oct 2019 31 Dec 2019
Q3 2019 -28.1 +21.7 +43.6% 01 Jul 2019 30 Sep 2019
Q2 2019 -30 +7.4 +19.8% 01 Apr 2019 30 Jun 2019
Q1 2019 -27.9 +8.37 +23.1% 01 Jan 2019 31 Mar 2019
Q4 2018 -65 01 Oct 2018 31 Dec 2018
Q3 2018 -49.8 01 Jul 2018 30 Sep 2018
Q2 2018 -37.4 01 Apr 2018 30 Jun 2018
Q1 2018 -36.3 01 Jan 2018 31 Mar 2018

Mersana Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -40 +22.6 +36.1% 01 Jan 2024 31 Dec 2024
2023 -62.6 +7.79 +11.1% 01 Jan 2023 31 Dec 2023
2022 -70.4 +3.09 +4.2% 01 Jan 2022 31 Dec 2022
2021 -73.5 -37.2 -102% 01 Jan 2021 31 Dec 2021
2020 -36.3 -14.5 -66.7% 01 Jan 2020 31 Dec 2020
2019 -21.8 +43.2 +66.5% 01 Jan 2019 31 Dec 2019
2018 -65 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.